Focal therapy for prostate cancer 1996: maximizing outcome.
暂无分享,去创建一个
P. Carroll | M. Roach | E. Small | M. Roach | M. Roach | P R Carroll | M Roach | J C Presti | J. Presti | E Small | Peter R. Carroll | J. Presti
[1] R. Weichselbaum,et al. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[2] J. Oesterling,et al. Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.
[3] G. Chen,et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. , 1993, International journal of radiation oncology, biology, physics.
[4] P. Scardino,et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.
[5] A. Coldman,et al. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. , 1990, Cancer research.
[6] J. Blasko,et al. Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. , 1995, The Journal of urology.
[7] M. Roach,et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. , 1996, The Journal of urology.
[8] E. Jaffee,et al. Demonstration of a rational strategy for human prostate cancer gene therapy. , 1994, The Journal of urology.
[9] A. Partin,et al. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. , 1993, The Journal of urology.
[10] Galina Pizov,et al. Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.
[11] D. Beyer,et al. Guided brachytherapy for treatment of confined prostate cancer. , 1992, Urology.
[12] G. Casola,et al. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. , 1995, The Journal of urology.
[13] F. Lee,et al. US-guided percutaneous cryoablation of prostate cancer. , 1994, Radiology.
[14] P. Carroll,et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.
[15] N. Olson,et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.
[16] M. Benson,et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.
[17] G E Hanks,et al. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. , 1992, International journal of radiation oncology, biology, physics.
[18] S. Goldenberg,et al. Effects of intermittent androgen suppression on androgen‐dependent tumors. Apoptosis and serum prostate‐specific antigen , 1993, Cancer.
[19] A. Partin,et al. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells , 1994, The Prostate.
[20] J Roy,et al. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] M. Zelefsky,et al. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. , 1994, The Journal of urology.
[22] D. Grignon,et al. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. , 1994, Urology.
[23] L. Verhey,et al. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[24] P. Carroll,et al. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. , 1996, The Journal of urology.
[25] L. Verhey,et al. Defining treatment margins for six field conformal irradiation of localized prostate cancer. , 1994, International journal of radiation oncology, biology, physics.
[26] L. Klotz,et al. Intermittent endocrine therapy for advanced prostate cancer , 1986, Cancer.
[27] J. Moul,et al. Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer. , 1995, The Journal of urology.
[28] A. Pollack,et al. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. , 1994, International journal of radiation oncology, biology, physics.
[29] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[30] M Goitein,et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. , 1993, International journal of radiation oncology, biology, physics.
[31] C. Coogan,et al. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. , 1995, The Journal of urology.
[32] R. Geist. Reference range for prostate-specific antigen levels after external beam radiation therapy for adenocarcinoma of the prostate. , 1995, Urology.
[33] C C Ling,et al. A CT-based evaluation method for permanent implants: application to prostate. , 1993, International journal of radiation oncology, biology, physics.
[34] L. Verhey,et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.
[35] D. Kuban,et al. I–125 interstitial implantation for prostate cancer. What have we learned 10 years later? , 1989, Cancer.
[36] Jianxiang,et al. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. , 1995, Cancer research.
[37] W. R. Lee,et al. 2 Conformal technique dose escalation in prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/ml , 1995 .
[38] Boris Rubinsky,et al. Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.
[39] H. Sandler,et al. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] M. Gleave,et al. Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report. , 1995, Urology.
[41] P. Scardino,et al. PSA after definitive radiotherapy for clinically localized prostate cancer. , 1993, The Urologic clinics of North America.
[42] A. Hanlon,et al. External beam irradiation of prostate cancer. Conformal treatment techniques and outcomes for the 1990 , 1995 .
[43] W Blumenfeld,et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.
[44] D. Schultz,et al. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. , 1994, International journal of radiation oncology, biology, physics.
[45] F. Marshall,et al. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. , 1995, Urology.
[46] Zippe Cd. Cryosurgical ablation for prostate cancer : a current review , 1995 .
[47] A. Deblasio,et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.
[48] A. D'Amico,et al. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] M. Melamed,et al. Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma , 1994, The Prostate.
[50] R. Dreicer,et al. Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence. , 1994, The Journal of urology.
[51] Z Chang,et al. Development of a high-performance multiprobe cryosurgical device. , 1994, Biomedical instrumentation & technology.
[52] K. Russell,et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. , 1994, International journal of radiation oncology, biology, physics.
[53] Andrew A. Gage,et al. Critical temperature for skin necrosis in experimental cryosurgery. , 1980, Cryobiology.